Sheila E. Taube

• Lisa M. McShane9
• Daniel F. Hayes5
• Douglas G. Altman5
• Willi Sauerbrei5
• Anthony Rhodes3
• D. Craig Allred3
• Gary M. Clark3
• Jared N. Schwartz3
• Karen L. Hagerty3
• M. Elizabeth H. Hammond3
• Massimo Gion3
• Mitch Dowsett3
• Patrick L. Fitzgibbons3
• Soonmyung Paik3
• Thomas M. Wheeler3
• C. Kent Osborne2
• Daniel W. Visscher2
• David G. Hicks2
• Emina Torlakovic2
• Fred C.G.J. Sweep2
• Giuseppe Viale2
• Glenn Francis2
• Herbert A. Fritsche2
• Hironobu Sasano2

1. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

   著者: M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett, D. Craig Allred, Karen L. Hagerty, Sunil Badve, Patrick L. Fitzgibbons, Glenn Francis, Neil S. Goldstein, Malcolm Hayes, David G. Hicks, Susan C. Lester, Richard R. Love, Pamela B. Mangu, Lisa M. McShane, Keith Miller, C. Kent Osborne, Soonmyung Paik, Jane Perlmutter, Anthony Rhodes, Hironobu Sasano, Jared N. Schwartz, Fred C.G.J. Sweep, Sheila E. Taube, Emina Torlakovic, Paul N. Valenstein, Giuseppe Viale, Daniel W. Visscher, Thomas M. Wheeler, Roger Williams, James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 被引用: 4,267

2. REporting recommendations for tumour MARKer prognostic studies (REMARK)

   著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark - British Journal of Cancer 2005 被引用: 1,387

3. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

   著者: Willi Sauerbrei, Sheila E. Taube, Lisa M. McShane, Margaret M. Cavenagh, Douglas G. Altman - JNCI Journal of the National Cancer Institute 2018 被引用: 495

4. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

   著者: Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Côté, Mitch Dowsett, Patrick L. Fitzgibbons, Wedad Hanna, Amy S. Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine M. Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc J. van de Vijver, Thomas M. Wheeler, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2006 被引用: 4,475

5. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

   著者: M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett, D. Craig Allred, Karen L. Hagerty, Sunil Badve, Patrick L. Fitzgibbons, Glenn Francis, Neil S. Goldstein, Malcolm Hayes, David G. Hicks, Susan C. Lester, Richard R. Love, Pamela B. Mangu, Lisa M. McShane, Keith Miller, C. Kent Osborne, Soonmyung Paik, Jane Perlmutter, Anthony Rhodes, Hironobu Sasano, Jared N. Schwartz, Fred C.G.J. Sweep, Sheila E. Taube, Emina Torlakovic, Paul N. Valenstein, Giuseppe Viale, Daniel W. Visscher, Thomas M. Wheeler, Roger Williams, James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 被引用: 1,048

6. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

   著者: Douglas G. Altman, Lisa M. McShane, Willi Sauerbrei, Sheila E. Taube - BMC Medicine 2012 被引用: 1,032

7. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

   著者: Lyndsay N. Harris, Herbert A. Fritsche, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast - Journal of Clinical Oncology 2007 被引用: 2,216

8. Reporting recommendations for tumor marker prognostic studies (remark).

   著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, G M Clark - Breast Cancer Research and Treatment 2005 被引用: 2,085

9. A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

   著者: Sheila E. Taube, Gary M. Clark, Janet Dancey, Lisa M. McShane, Caroline C. Sigman, Steven Gutman - JNCI Journal of the National Cancer Institute 2009 被引用: 127

10. Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    著者: D. F. Hayes, Robert C. Bast, Christopher E. Desch, Herbert A. Fritsche, Nancy E. Kemeny, J. Milburn Jessup, Gershon Y. Locker, J. S. Macdonald, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, R Winn - JNCI Journal of the National Cancer Institute 1996 被引用: 752

11. Reporting Recommendations for Tumor Marker Prognostic Studies

    著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark - Journal of Clinical Oncology 2005 被引用: 775

12. Breaking a Vicious Cycle

    著者: Daniel F. Hayes, Jeff Allen, Carolyn C. Compton, Gary Gustavsen, Debra G. B. Leonard, Robert McCormack, Lee N. Newcomer, Kristin Pothier, David F. Ransohoff, Richard L. Schilsky, Ellen V. Sigal, Sheila E. Taube, Sean Tunis - Science Translational Medicine 2013 被引用: 121

13. Influence of inhibitors of protein synthesis on interferon formation in mice

    著者: Julius S. Youngner, Warren R. Stinebring, Sheila E. Taube - Virology 1965 被引用: 107

14. A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network

    著者: Thomas A. Drake, Jonathan Braun, Alberto M. Marchevsky, Isaac S. Kohane, Christopher D.�M. Fletcher, Henry C. Chueh, Bruce A. Beckwith, David Berkowicz, Frank C. Kuo, Qing Zeng, Ulysses J. Balis, Ana Holzbach, Andrew McMurry, Connie E. Gee, Clement J. McDonald, Gunther Schadow, Mary M. Davis, Eyas M. Hattab, Lonnie Blevins, J. N. Hook, Michael J. Becich, Rebecca S. Crowley, Sheila E. Taube, Jules J. Berman - Human Pathology 2007 被引用: 37

全 14 件を表示しました。